Johnson Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$384K Buy
320
+17
+6% +$17.4K 0.16% 39
2026
Q1
$279K Buy
303
+68
+29% +$68.9K 0.13% 45
2025
Q4
$253K Buy
+235
New +$225K 0.13% 48

Other funds holding LLY

Johnson Wealth Management's LLY Position: Q2 2026 in Review

Johnson Wealth Management increased its Eli Lilly (LLY) stake by 5.6% in Q2 2026, buying an estimated $17.4K and bringing the position to 320 shares worth $384K. The position accounts for 0.16% of the portfolio, ranked #39.

Johnson Wealth Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Johnson Wealth Management held 320 shares of Eli Lilly worth $384K as of Q2 2026.
  • Johnson Wealth Management bought 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
  • Eli Lilly made up 0.16% of Johnson Wealth Management's portfolio in Q2 2026, its #39 holding.
  • Johnson Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Johnson Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.